Ontology highlight
ABSTRACT: Background
There are 3 main epileptic conditions in hospital settings that may require intravenous antiepileptic treatment: status epilepticus, acute repetitive convulsive seizures, and postoperative seizures. Generic intravenous levetiracetam (IV LEV) (Focale; Great Eastern Drug Co, Bangkok, Thailand), has been reported to have comparable efficacy to original IV LEV for treating status epilepticus and acute repetitive convulsive seizures in a randomized controlled trial. At present, there are limited data on the efficacy and tolerability of generic intravenous LEV in real-world situations.Objective
This study aimed to evaluate the clinical outcomes of generic IV LEV in a real-world setting.Methods
A retrospective study and analyses were conducted. All adult patient
SUBMITTER: Ruangritkul P
PROVIDER: S-EPMC8605403 | biostudies-literature | 2021
REPOSITORIES: biostudies-literature